(Reuters) - Johnson & Johnson said on Friday it would acquire the remaining stake in Verb Surgical Inc, from Verily, Alphabet Inc’s life sciences division.
Bolstering its Ethicon unit, which makes surgical equipment, J&J in 2015 formed an independent company called Verb Surgical with Verily to create smaller, smarter and less costly robotic-assisted systems for surgery. (reut.rs/2EBtI9j)
The deal for Verb Surgical is expected to close in the first half of 2020, J&J said without disclosing deal terms.
J&J pushed further into the surgical robotics space with its $3.4-billion acquisition of Auris Health Inc earlier this year. The deal gave J&J access to the privately held company’s surgical robotic scope used in respiratory procedures and the detection of lung cancer.
The acquisition of Auris accelerated J&J’s entry into digital surgery, kicking off a strong pipeline of launches that will take place over the next several years, J&J said on Friday.
Reporting by Manojna Maddipatla in Bengaluru; Editing by Shounak Dasgupta